BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reid A, Scano F, Getahun H, Williams B, Dye C, Nunn P, De Cock KM, Hankins C, Miller B, Castro KG, Raviglione MC. Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. The Lancet Infectious Diseases 2006;6:483-95. [DOI: 10.1016/s1473-3099(06)70549-7] [Cited by in Crossref: 79] [Cited by in F6Publishing: 89] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Girum T, Yasin F, Dessu S, Zeleke B, Geremew M. “Universal test and treat” program reduced TB incidence by 75% among a cohort of adults taking antiretroviral therapy (ART) in Gurage zone, South Ethiopia. Trop Dis Travel Med Vaccines 2020;6:12. [DOI: 10.1186/s40794-020-00113-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Cavalin RF, Pellini ACG, Lemos RRG, Sato APS. TB-HIV co-infection: spatial and temporal distribution in the largest Brazilian metropolis. Rev Saude Publica 2020;54:e112. [PMID: 33146301 DOI: 10.11606/s1518-8787.2020054002108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Adoyo MA. Landscape analysis of healthcare policy: the instrumental role of governance in HIV/AIDS services integration framework. Pan Afr Med J 2020;36:27. [PMID: 32774604 DOI: 10.11604/pamj.2020.36.27.22795] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Li M, Yu W, Tian W, Ge Y, Liu Y, Ding T, Zhang L. System dynamics modeling of public health services provided by China CDC to control infectious and endemic diseases in China. Infect Drug Resist 2019;12:613-25. [PMID: 30936725 DOI: 10.2147/IDR.S185177] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
5 Atmanto GE, Maranatha D. SEORANG WANITA DENGAN TB PARU KASUS BARU DAN TB EKSTRA PARU MULTIPLE. JR 2019;5:10. [DOI: 10.20473/jr.v5-i.1.2019.10-14] [Reference Citation Analysis]
6 Raviglione MC. Evolution of the strategies for control and elimination of tuberculosis. Tuberculosis. [DOI: 10.1183/2312508x.10020817] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Katzenellenbogen JM, Ralph AP, Wyber R, Carapetis JR. Rheumatic heart disease: infectious disease origin, chronic care approach. BMC Health Serv Res 2017;17:793. [PMID: 29187184 DOI: 10.1186/s12913-017-2747-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
8 Sotgiu G. OBSOLETE: Tuberculosis Epidemiology. Reference Module in Biomedical Sciences 2017. [DOI: 10.1016/b978-0-12-801238-3.98778-6] [Reference Citation Analysis]
9 Oppong JR, Lester KA. HIV/AIDS and Tuberculosis. International Encyclopedia of Public Health 2017. [DOI: 10.1016/b978-0-12-803678-5.00213-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Sotgiu G, Glaziou P, Sismanidis C, Raviglione M. Tuberculosis Epidemiology. International Encyclopedia of Public Health 2017. [DOI: 10.1016/b978-0-12-803678-5.00507-5] [Reference Citation Analysis]
11 Walls G, Bulifon S, Breysse S, Daneth T, Bonnet M, Hurtado N, Molfino L. Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia. Glob Health Action 2015;8:25964. [PMID: 25623609 DOI: 10.3402/gha.v8.25964] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Long R, Niruban S, Heffernan C, Cooper R, Fisher D, Ahmed R, Egedahl ML, Fur R. A 10-year population based study of 'opt-out' HIV testing of tuberculosis patients in Alberta, Canada: national implications. PLoS One 2014;9:e98993. [PMID: 24911262 DOI: 10.1371/journal.pone.0098993] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
13 Ugarte-Gil C, Ponce M, Zamudio C, Canaza L, Samalvides F, Seas C. Knowledge about HIV prevention and transmission among recently diagnosed tuberculosis patients: a cross sectional study. BMC Public Health 2013;13:1237. [PMID: 24373517 DOI: 10.1186/1471-2458-13-1237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 Han SH, Zhou J, Lee MP, Zhao H, Chen YM, Kumarasamy N, Pujari S, Lee C, Omar SF, Ditangco R, Phanuphak N, Kiertiburanakul S, Chaiwarith R, Merati TP, Yunihastuti E, Tanuma J, Saphonn V, Sohn AH, Choi JY; TREAT Asia HIV Observational Database. Prognostic significance of the interval between the initiation of antiretroviral therapy and the initiation of anti-tuberculosis treatment in HIV/tuberculosis-coinfected patients: results from the TREAT Asia HIV Observational Database. HIV Med 2014;15:77-85. [PMID: 23980589 DOI: 10.1111/hiv.12073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
15 Addis Alene K, Nega A, Wasie Taye B. Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect Dis 2013;13:292. [PMID: 23806088 DOI: 10.1186/1471-2334-13-292] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
16 Taylor AW, Mosimaneotsile B, Mathebula U, Mathoma A, Moathlodi R, Theebetsile I, Samandari T. Pregnancy outcomes in HIV-infected women receiving long-term isoniazid prophylaxis for tuberculosis and antiretroviral therapy. Infect Dis Obstet Gynecol 2013;2013:195637. [PMID: 23533318 DOI: 10.1155/2013/195637] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
17 Ku NS, Oh JO, Shin SY, Kim SB, Kim HW, Jeong SJ, Han SH, Song YG, Kim JM, Choi JY. Effects of tuberculosis on the kinetics of CD4(+) T cell count among HIV-infected patients who initiated antiretroviral therapy early after tuberculosis treatment. AIDS Res Hum Retroviruses 2013;29:226-30. [PMID: 22881387 DOI: 10.1089/AID.2012.0192] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
18 Sotgiu G, Zignol M, Raviglione MC. Tuberculosis, Epidemiology of. Infectious Diseases 2013. [DOI: 10.1007/978-1-4614-5719-0_12] [Reference Citation Analysis]
19 Ansa GA, Walley JD, Siddiqi K, Wei X. Assessing the impact of TB/HIV services integration on TB treatment outcomes and their relevance in TB/HIV monitoring in Ghana. Infect Dis Poverty 2012;1:13. [PMID: 23849044 DOI: 10.1186/2049-9957-1-13] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
20 Adekeye OA, Heiman HJ, Onyeabor OS, Hyacinth HI. The new invincibles: HIV screening among older adults in the U.S. PLoS One 2012;7:e43618. [PMID: 22952722 DOI: 10.1371/journal.pone.0043618] [Cited by in Crossref: 35] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
21 Sotgiu G, Zignol M, Raviglione MC. Tuberculosis, Epidemiology of. Encyclopedia of Sustainability Science and Technology 2012. [DOI: 10.1007/978-1-4419-0851-3_852] [Reference Citation Analysis]
22 Armbruster B, Helleringer S, Kalilani-Phiri L, Mkandawire J, Kohler HP. Exploring the relative costs of contact tracing for increasing HIV case finding in sub-Saharan countries. J Acquir Immune Defic Syndr 2011;58:e29-36. [PMID: 21725247 DOI: 10.1097/QAI.0b013e31822a9fa8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
23 Hijikata M, Shojima J, Matsushita I, Tokunaga K, Ohashi J, Hang NT, Horie T, Sakurada S, Hoang NP, Thuong PH, Lien LT, Keicho N. Association of IFNGR2 gene polymorphisms with pulmonary tuberculosis among the Vietnamese. Hum Genet 2012;131:675-82. [PMID: 22057826 DOI: 10.1007/s00439-011-1112-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
24 Wells CD. Global Impact of Multidrug-Resistant Pulmonary Tuberculosis Among HIV-Infected and Other Immunocompromised Hosts: Epidemiology, Diagnosis, and Strategies for Management. Curr Infect Dis Rep 2010;12:192-7. [PMID: 21308529 DOI: 10.1007/s11908-010-0104-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
25 Bharucha NE, Raven RH, Nambiar V. Tuberculosis. The Causes of Epilepsy 2011. [DOI: 10.1017/cbo9780511921001.075] [Reference Citation Analysis]
26 Said HM, Ismail N, Osman A, Velsman C, Hoosen AA. Evaluation of TBc identification immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex in samples from broth cultures. J Clin Microbiol 2011;49:1939-42. [PMID: 21411594 DOI: 10.1128/JCM.01906-10] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
27 Rose JM, Washington R, Krishnamurthy J, Pise G, Perumpil M, Gurnani V, Moses S. Morbidity Profiles of People Living With HIV/AIDS in Urban and Rural Inpatient and Outpatient Settings in Karnataka, South India. J Int Assoc Physicians AIDS Care (Chic) 2011;10:12-7. [PMID: 21266321 DOI: 10.1177/1545109710374773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
28 Au-Yeung C, Kanters S, Ding E, Glaziou P, Anema A, Cooper CL, Montaner JS, Hogg RS, Mills EJ. Tuberculosis mortality in HIV-infected individuals: a cross-national systematic assessment. Clin Epidemiol 2011;3:21-9. [PMID: 21326656 DOI: 10.2147/CLEP.S15574] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
29 Campion S, Cohen MS, McMichael AJ, Galvin S, Goonetilleke N. Improved detection of latent Mycobacterium tuberculosis infection in HIV-1 seropositive individuals using cultured cellular assays. Eur J Immunol 2011;41:255-7. [PMID: 21182097 DOI: 10.1002/eji.201040296] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
30 Uhler LM, Kumarasamy N, Mayer KH, Saxena A, Losina E, Muniyandi M, Stoler AW, Lu Z, Walensky RP, Flanigan TP, Bender MA, Freedberg KA, Swaminathan S; CEPAC International investigators. Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India. PLoS One 2010;5:e12747. [PMID: 20862279 DOI: 10.1371/journal.pone.0012747] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
31 Jassal MS, Bishai WR. Epidemiology and challenges to the elimination of global tuberculosis. Clin Infect Dis 2010;50 Suppl 3:S156-64. [PMID: 20397943 DOI: 10.1086/651486] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 3.7] [Reference Citation Analysis]
32 Scott V, Chopra M, Azevedo V, Caldwell J, Naidoo P, Smuts B. Scaling up integration: development and results of a participatory assessment of HIV/TB services, South Africa. Health Res Policy Syst 2010;8:23. [PMID: 20626884 DOI: 10.1186/1478-4505-8-23] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
33 Beaulière A, Le Maux A, Trehin C, Perez F. Accès aux traitements antirétroviraux dans les pays en développement : quelles stratégies de financement ? Revue d'Épidémiologie et de Santé Publique 2010;58:e1-e10. [DOI: 10.1016/j.respe.2010.02.109] [Reference Citation Analysis]
34 Kherad O, Herrmann FR, Zellweger JP, Rochat T, Janssens JP. Clinical presentation, demographics and outcome of tuberculosis (TB) in a low incidence area: a 4-year study in Geneva, Switzerland. BMC Infect Dis 2009;9:217. [PMID: 20043847 DOI: 10.1186/1471-2334-9-217] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
35 Gebrekristos HT, Lurie MN, Mthethwa N, Karim QA. Disclosure of HIV status: Experiences of Patients Enrolled in an Integrated TB and HAART Pilot Programme in South Africa. Afr J AIDS Res 2009;8:1-6. [PMID: 20411037 DOI: 10.2989/AJAR.2009.] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
36 Deretic V, Delgado M, Vergne I, Master S, De Haro S, Ponpuak M, Singh S. Autophagy in immunity against mycobacterium tuberculosis: a model system to dissect immunological roles of autophagy. Curr Top Microbiol Immunol 2009;335:169-88. [PMID: 19802565 DOI: 10.1007/978-3-642-00302-8_8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 83] [Article Influence: 3.4] [Reference Citation Analysis]
37 Datiko DG, Yassin MA, Chekol LT, Kabeto LE, Lindtjørn B. The rate of TB-HIV co-infection depends on the prevalence of HIV infection in a community. BMC Public Health 2008;8:266. [PMID: 18667068 DOI: 10.1186/1471-2458-8-266] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 2.0] [Reference Citation Analysis]
38 Sánchez MS, Lloyd-Smith JO, Porco TC, Williams BG, Borgdorff MW, Mansoer J, Salomon JA, Getz WM. Impact of HIV on novel therapies for tuberculosis control. AIDS 2008;22:963-72. [PMID: 18453856 DOI: 10.1097/QAD.0b013e3282f7cb4b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
39 Koenig SP, Riviere C, Leger P, Severe P, Atwood S, Fitzgerald DW, Pape JW, Schackman BR. The cost of antiretroviral therapy in Haiti. Cost Eff Resour Alloc 2008;6:3. [PMID: 18275615 DOI: 10.1186/1478-7547-6-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
40 Goldfeld AE, Ranjbar S, Tsitsikov EN. Tuberculosis/Human Immunodeficiency Virus Coinfection and the Host Immune Response. Handbook of Tuberculosis 2008. [DOI: 10.1002/9783527611614.ch30] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
41 Goletti D, Carrara S, Mayanja-Kizza H, Baseke J, Mugerwa MA, Girardi E, Toossi Z. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect Dis 2008;8:11. [PMID: 18226199 DOI: 10.1186/1471-2334-8-11] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
42 Bao QS, Du YH, Lu CY. Treatment outcome of new pulmonary tuberculosis in Guangzhou, China 1993-2002: a register-based cohort study. BMC Public Health 2007;7:344. [PMID: 18047661 DOI: 10.1186/1471-2458-7-344] [Cited by in Crossref: 23] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
43 Bagchi AK. Governing the market in health care: the social and political requirements. The Economics of Health Equity 2007. [DOI: 10.1017/cbo9780511544460.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
44 Laserson KF, Wells CD. Reaching the targets for tuberculosis control: the impact of HIV. Bull World Health Organ 2007;85:377-81; discussion 382-6. [PMID: 17639223 DOI: 10.2471/blt.06.035329] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
45 Coninx R. Tuberculosis in complex emergencies. Bull World Health Organ 2007;85:637-40. [PMID: 17768523 DOI: 10.2471/blt.06.037630] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
46 Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, King BS, Efron A, Moore RD, Chaisson RE, Durovni B. The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2007;21:1441-8. [PMID: 17589190 DOI: 10.1097/QAD.0b013e328216f441] [Cited by in Crossref: 196] [Cited by in F6Publishing: 222] [Article Influence: 12.3] [Reference Citation Analysis]
47 Boyd MA, Cooper DA. Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research. AIDS 2007;21 Suppl 4:S55-63. [PMID: 17620754 DOI: 10.1097/01.aids.0000279707.01557.b2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
48 Ferwerda B, Kibiki GS, Netea MG, Dolmans WM, van der Ven AJ. The toll-like receptor 4 Asp299Gly variant and tuberculosis susceptibility in HIV-infected patients in Tanzania. AIDS 2007;21:1375-7. [PMID: 17545720 DOI: 10.1097/QAD.0b013e32814e6b2d] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
49 Zachariah R, Harries AD, Manzi M, Gomani P, Teck R, Phillips M, Firmenich P. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS One 2006;1:e121. [PMID: 17205125 DOI: 10.1371/journal.pone.0000121] [Cited by in Crossref: 70] [Cited by in F6Publishing: 90] [Article Influence: 4.1] [Reference Citation Analysis]